{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:25:54Z","timestamp":1790115954352,"version":"4.0.1"},"reference-count":19,"publisher":"The Editorial Office of Gut and Liver","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut Liver"],"published-print":{"date-parts":[[2016,5,23]]},"DOI":"10.5009\/gnl15129","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T01:35:15Z","timestamp":1448415315000},"source":"Crossref","is-referenced-by-count":12,"title":["The IL-1B Genetic Polymorphism Is Associated with Aspirin-Induced PepticUlcers in a Korean Ethnic Group"],"prefix":"10.5009","volume":"10","author":[{"given":"Jae Hee","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Sung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Wook","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangheun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Jun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Man","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2920","reference":[{"key":"ref1","first-page":"229","article-title":"Incidence of and risk factors for upper gastrointestinal complications in patients taking low-dose aspirin in Japan","volume":"58","author":"Fujisawa, N","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2036.2005.02649.x","article-title":"Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin","volume":"22","author":"Yeomans, ND","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/hrt.2010.217547","article-title":"Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)","volume":"97","author":"Scheiman, JM","year":"2011","journal-title":"Heart"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00535-008-2206-5","article-title":"Low-dose aspirin-induced gastrointestinal diseases: past, present, and future","volume":"43","author":"Shiotani, A","year":"2008","journal-title":"J Gastroenterol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1185\/030079907X162656","article-title":"Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment","volume":"23","author":"Lanas, A","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"ref6","first-page":"373","article-title":"Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan","volume":"20","author":"Arisawa, T","year":"2007","journal-title":"Int J Mol Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1067\/mcp.2003.1","article-title":"Genetic variation in cyclooxygenase 1: effects on response to aspirin","volume":"73","author":"Halushka, MK","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00535-009-0068-0","article-title":"The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy","volume":"44","author":"Shiotani, A","year":"2009","journal-title":"J Gastroenterol"},{"issue":"Suppl 1","key":"ref9","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1111\/j.1440-1746.2009.06212.x","article-title":"Aspirin-induced peptic ulcer and genetic polymorphisms","volume":"25","author":"Shiotani, A","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1111\/j.1538-7836.2005.01555.x","article-title":"Cyclooxygenase-1 haplotype modulates platelet response to aspirin","volume":"3","author":"Maree, AO","year":"2005","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1160\/TH08-11-0753","article-title":"Cy-clooxygenase-1 haplotype C50T\/A-842G does not affect platelet response to aspirin","volume":"101","author":"Pettinella, C","year":"2009","journal-title":"Thromb Haemost"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1007\/s10620-006-9475-8","article-title":"Effect of a specific cyclooxygenase-gene polymorphism (A-842G\/C50T) on the occurrence of peptic ulcer hemorrhage","volume":"51","author":"van Oijen, MG","year":"2006","journal-title":"Dig Dis Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2125.2008.03183.x","article-title":"Pharmacogenetics of aspirin resistance: a comprehensive systematic review","volume":"66","author":"Goodman, T","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2217\/14622416.8.6.577","article-title":"Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin","volume":"8","author":"Li, Q","year":"2007","journal-title":"Pharmacogenomics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gut.48.6.743","article-title":"The importance of interleukin 1beta in Helicobacter pylori associated disease","volume":"48","author":"El-Omar, EM","year":"2001","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar, EM","year":"2000","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.4049\/jimmunol.1002402","article-title":"The IL1RN promoter rs4251961 correlates with IL-1 receptor antagonist concentrations in human infection and is differentially regulated by GATA-1","volume":"186","author":"Carrol, ED","year":"2011","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.gene.6364393","article-title":"Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels","volume":"8","author":"Rafiq, S","year":"2007","journal-title":"Genes Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.dld.2011.10.005","article-title":"Association of SLCO1B1 1b with peptic ulcer amongst Japanese patients taking low-dose aspirin","volume":"44","author":"Shiotani, A","year":"2012","journal-title":"Dig Liver Dis"}],"container-title":["Gut and Liver"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/ekjg\/ekjg010-03-10.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T18:02:35Z","timestamp":1567360955000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.gutnliver.org\/journal\/view.html?doi=10.5009\/gnl15129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5,23]]}},"alternative-id":["10.5009\/gnl15129"],"URL":"https:\/\/doi.org\/10.5009\/gnl15129","relation":{},"ISSN":["1976-2283","2005-1212"],"issn-type":[{"value":"1976-2283","type":"print"},{"value":"2005-1212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]}}}